Related Experiment Videos
Incisionless in-office castration using a veterinary castration device (Burdizzo clamp)
Michael E Herzog1, Richard A Santucci
1Department of Urology, Wayne State University School of Medicine, Detroit, Michigan 48167, USA.
Urology
|May 29, 2002
Summary
Incisionless castration using a Burdizzo clamp achieved effective testosterone suppression in a transgender patient. This minimally invasive technique offers a potential alternative for castration in transgender individuals and prostate cancer patients.
Area of Science:
- Urology
- Endocrinology
- Surgical Innovation
Background:
- Traditional castration methods involve surgical incision, leading to potential pain, scarring, and complications.
- Nonoperative testicular artery ablation using the Burdizzo clamp has been documented in animal studies but not previously in humans.
Observation:
- A case report details the successful application of the Burdizzo clamp for bilateral spermatic cord ablation under local anesthesia in a transgender patient.
- The patient sought an alternative to open castration to avoid pain, expense, and scarring.
Findings:
- The Burdizzo clamp effectively crushed the spermatic cord, inducing testicular atrophy and subsequent testosterone reduction to castrate levels.
- Minimal soft-tissue damage was observed post-procedure, indicating a favorable safety profile.
Implications:
- This minimally invasive technique presents a viable, less burdensome option for castration in transgender individuals.
- The approach may also be applicable for castration in patients diagnosed with advanced prostate cancer, offering a novel therapeutic avenue.